Publications: Neurocognition

Opler, L.A., Medalia, A., Opler, M.G., & Stahl, S.M. (2013). Pharmacotherapy of cognitive deficits in schizophrenia. CNS Spectr. 2013 Nov 8:1-15.


Lindenmayer, J.P., & Khan, A. (2011). Galantamine Augmentation of Long Acting Injectable Risperidone for Cognitive Impairments in Chronic Schizophrenia. Schizophrenia Research, 125(2-3), 267-77. doi: 10.1016/j.schres.2010.08.021


Lindenmayer, J.P., Kaushik, S., Branch, C., McGurk, S., Khan, A., Li, H., & Hoffman, L. (2008). Does computerized cognitive remediation change brain activation patterns in schizophrenia? fMRI pilot data. European Psychiatry, 23[Suppl. 2], S127-S128.


Lindenmayer, J.P., McGurk, S.R., Mueser, K.T., Khan, A., Wance, D., Hoffman, L., Wolfe, R., & Xie, H. (Mar, 2008). A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness. Psychiatr Serv. 59(3), 241-7. doi: 10.1176/appi.ps.59.3.241


Lindenmayer, J.P., McGurk, S.R., Mueser, K.T., Khan, A., Hoffman, L., & Wance, D. (2007). Predicting improvement on a computerized cognitive remediation program in patients with schizophrenia. Biol Psychiatry, 61, 1S-266S.


Serper, M.R., & Allen, M.H. (2002). Rapid Screening for Cognitive Impairment in the Psychiatric Emergency Service I: Cognitive Screening Batteries. Psychiatric Services, 53, 1527-1529.

 

 

<< Back to All Publications